Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
- PMID: 33767447
- DOI: 10.1038/s41586-021-03470-x
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
Abstract
The SARS-CoV-2 lineage B.1.1.7, designated variant of concern (VOC) 202012/01 by Public Health England1, was first identified in the UK in late summer to early autumn 20202. Whole-genome SARS-CoV-2 sequence data collected from community-based diagnostic testing for COVID-19 show an extremely rapid expansion of the B.1.1.7 lineage during autumn 2020, suggesting that it has a selective advantage. Here we show that changes in VOC frequency inferred from genetic data correspond closely to changes inferred by S gene target failures (SGTF) in community-based diagnostic PCR testing. Analysis of trends in SGTF and non-SGTF case numbers in local areas across England shows that B.1.1.7 has higher transmissibility than non-VOC lineages, even if it has a different latent period or generation time. The SGTF data indicate a transient shift in the age composition of reported cases, with cases of B.1.1.7 including a larger share of under 20-year-olds than non-VOC cases. We estimated time-varying reproduction numbers for B.1.1.7 and co-circulating lineages using SGTF and genomic data. The best-supported models did not indicate a substantial difference in VOC transmissibility among different age groups, but all analyses agreed that B.1.1.7 has a substantial transmission advantage over other lineages, with a 50% to 100% higher reproduction number.
Similar articles
-
Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7.Nature. 2021 May;593(7858):270-274. doi: 10.1038/s41586-021-03426-1. Epub 2021 Mar 15. Nature. 2021. PMID: 33723411 Free PMC article.
-
Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19).2023 May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 34033342 Free Books & Documents.
-
Genomic Surveillance of SARS-CoV-2 Lineages Indicates Early Circulation of P.1 (Gamma) Variant of Concern in Southern Brazil.Microbiol Spectr. 2022 Feb 23;10(1):e0151121. doi: 10.1128/spectrum.01511-21. Epub 2022 Feb 16. Microbiol Spectr. 2022. PMID: 35171035 Free PMC article.
-
Genomic reconstruction of the SARS-CoV-2 epidemic in England.Nature. 2021 Dec;600(7889):506-511. doi: 10.1038/s41586-021-04069-y. Epub 2021 Oct 14. Nature. 2021. PMID: 34649268 Free PMC article.
-
Omicron Genetic and Clinical Peculiarities That May Overturn SARS-CoV-2 Pandemic: A Literature Review.Int J Mol Sci. 2022 Feb 11;23(4):1987. doi: 10.3390/ijms23041987. Int J Mol Sci. 2022. PMID: 35216104 Free PMC article. Review.
Cited by
-
Virological Characterization of Critically Ill Patients With COVID-19 in the United Kingdom: Interactions of Viral Load, Antibody Status, and B.1.1.7 Infection.J Infect Dis. 2021 Aug 16;224(4):595-605. doi: 10.1093/infdis/jiab283. J Infect Dis. 2021. PMID: 34031695 Free PMC article.
-
Estimation of Secondary Household Attack Rates for Emergent Spike L452R Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Detected by Genomic Surveillance at a Community-Based Testing Site in San Francisco.Clin Infect Dis. 2022 Jan 7;74(1):32-39. doi: 10.1093/cid/ciab283. Clin Infect Dis. 2022. PMID: 33788923 Free PMC article.
-
Comparison of Clinical Characteristics and Outcomes of Hospitalized Patients Infected with the D614G Strain or Alpha Variant of COVID-19 in Taiwan: A Multi-Center Cohort Study.Int J Med Sci. 2022 Oct 24;19(13):1912-1919. doi: 10.7150/ijms.76725. eCollection 2022. Int J Med Sci. 2022. PMID: 36438919 Free PMC article.
-
SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines.Front Microbiol. 2024 Jun 13;15:1334152. doi: 10.3389/fmicb.2024.1334152. eCollection 2024. Front Microbiol. 2024. PMID: 38939189 Free PMC article. Review.
-
SARS-CoV-2 Omicron detection by antigen tests using saliva.J Clin Virol Plus. 2022 Nov;2(4):100109. doi: 10.1016/j.jcvp.2022.100109. Epub 2022 Sep 13. J Clin Virol Plus. 2022. PMID: 36118305 Free PMC article.
References
-
- Public Health England Investigation of novel SARS-COV-2 variant 202012/01: technical briefing 1 https://www.gov.uk/government/publications/investigation-of-novel-sars-c... (2020).
-
- Rambaut, A. et al. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. https://virological.org/t/preliminary-genomic-characterisation-of-an-eme... (2020).
-
- Chan, K. K., Tan, T. J. C., Narayanan, K. K. & Procko, E. An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants. Sci. Adv. 7, eabf1738 (2021).
-
- Starr, T. N. et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell 182, 1295–1310.e20 (2020). - DOI
-
- Gu, H. et al. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy. Science 369, 1603–1607 (2020). - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous